Evaluation of a DNA microarray for the rapid detection of extended-spectrum -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM)

被引:113
作者
Cuzon, Gaelle [1 ]
Naas, Thierry [1 ]
Bogaerts, Pierre [2 ]
Glupczynski, Youri [2 ]
Nordmann, Patrice [1 ]
机构
[1] Hop Bicetre, AP HP, Serv Bacteriol Virol, INSERM Emerging Resistance Antibiot U914,Fac Med, F-94275 Le Kremlin Bicetre, France
[2] Clin Univ UCL Mt Godinne, Bacteriol Lab, Yvoir, Belgium
关键词
clinically relevant -lactamases; acquired; -lactamases; culture; BETA-LACTAMASES;
D O I
10.1093/jac/dks156
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Carbapenem-resistant Gram-negative bacilli are reported increasingly and represent an emerging public health concern. Laboratory detection of extended-spectrum -lactamase (ESBL), plasmid-mediated cephalosporinase (pAmpC) and carbapenemase producers remains a challenge for microbiology laboratories and is important to avoid clinical failure due to inappropriate antimicrobial therapy and to prevent nosocomial outbreaks. We evaluated a novel microarray, the oCheck-MDR CT103 array' test (Check-Points, Wageningen, The Netherlands), that employs highly specific DNA markers to identify the -lactamase genes of ESBLs (TEM, SHV and CTX-M, and discriminates between ESBL and non-ESBL TEM and SHV variants), of pAmpC (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and of carbapenemases (KPC, OXA-48, VIM, IMP and NDM). One-hundred-and-eighty-seven well-characterized Gram-negative bacilli isolates possessing different bla genes were tested. Total DNAs were extracted using a Qiagen DNA mini kit. The oCheck-MDR CT103 array' was used as recommended by the manufacturer. The system correctly identified representatives of the three ESBL gene families tested, including differentiation between non-ESBL and ESBL TEM and SHV variants. All bla(CTX-M) genes were classified into the appropriate family group (i.e. CTX-M-1 group, CTX-M-2 group, CTX-M-9 group and CTX-M-8/25/26 group). In addition, the clinically relevant plasmid-encoded cephalosporinase and carbapenemase genes were also reliably detected. Specificities and sensitivities of 100 were recorded for most bla genes. The oCheck-MDR CT103 array' is a powerful high-throughput tool for rapid identification of ESBL, pAmpC and carbapenemase producers in culture. Because of its rapid performance, this platform is a valuable tool for epidemiological or infection control studies.
引用
收藏
页码:1865 / 1869
页数:5
相关论文
共 11 条
  • [1] Multicenter Evaluation of a New DNA Microarray for Rapid Detection of Clinically Relevant bla Genes from β-Lactam-Resistant Gram-Negative Bacteria
    Bogaerts, Pierre
    Hujer, Andrea M.
    Naas, Thierry
    de Castro, Roberta Rezende
    Endimiani, Andrea
    Nordmann, Patrice
    Glupczynski, Youri
    Bonomo, Robert A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (09) : 4457 - 4460
  • [2] Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
    Bush, Karen
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2010, 13 (05) : 558 - 564
  • [3] Use of ChromID Extended-Spectrum β-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae
    Carrer, Amelie
    Fortineau, Nicolas
    Nordmann, Patrice
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (05) : 1913 - 1914
  • [4] AmpC β-Lactamases
    Jacoby, George A.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2009, 22 (01) : 161 - +
  • [5] CTX-M: changing the face of ESBLs in Europe
    Livermore, David M.
    Canton, Rafael
    Gniadkowski, Marek
    Nordmann, Patrice
    Rossolini, Gian Maria
    Arlet, Guillaume
    Ayala, Juan
    Coque, Teresa M.
    Kern-Zdanowicz, Izabela
    Luzzaro, Francesco
    Poirel, Laurent
    Woodford, Neil
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (02) : 165 - 174
  • [6] Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
    Miriagou, V.
    Cornaglia, G.
    Edelstein, M.
    Galani, I.
    Giske, C. G.
    Gniadkowski, M.
    Malamou-Lada, E.
    Martinez-Martinez, L.
    Navarro, F.
    Nordmann, P.
    Peixe, L.
    Pournaras, S.
    Rossolini, G. M.
    Tsakris, A.
    Vatopoulos, A.
    Canton, R.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) : 112 - 122
  • [7] Minor extended-spectrum β-lactamases
    Naas, T.
    Poirel, L.
    Nordmann, P.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 42 - 52
  • [8] Evaluation of a DNA Microarray, the Check-Points ESBL/KPC Array, for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and KPC Carbapenemases
    Naas, T.
    Cuzon, G.
    Truong, H.
    Bernabeu, S.
    Nordmann, P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3086 - 3092
  • [9] Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases
    Naas, Thierry
    Cuzon, Gaelle
    Bogaerts, Pierre
    Glupczynski, Youri
    Nordmann, Patrice
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (04) : 1608 - 1613
  • [10] Global Spread of Carbapenemase-producing Enterobacteriaceae
    Nordmann, Patrice
    Naas, Thierry
    Poirel, Laurent
    [J]. EMERGING INFECTIOUS DISEASES, 2011, 17 (10) : 1791 - 1798